Launched in 1992, the 340B program requires drug manufacturers that participate in Medicaid to provide outpatient medications at substantial discounts to providers that serve large numbers of uninsured, underinsured and Medicaid patients. #drugpricing #lawmakers #capitolnewsillinois
Providers warn that recent actions by pharmaceutical manufacturers restricting how and where discounted medications can be dispensed are threatening the program, forcing hospitals and clinics to make difficult choices and putting patient care at risk in urban, suburban, and rural communities. #healthcare #drug #pricing
Under the program, eligible health care providers may apply for up to $3 million in capital improvement funding to upgrade facilities, expand capacity, or modernize infrastructure. #healthcenters #grant